Humanin

Research

Humanin (HN)

Aliases
Mitochondrial-derived peptide (MDP)
Administration
Subcutaneous injection (research)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Effects are generally described as subtle, if present, given the compound's cellular-level mechanism.

  2. 2

    3–4 Weeks

    No consistent early felt pattern has been established in available research.

  3. 3

    5–7 Weeks

    Limited human trial data makes a felt timeline difficult to characterize at this stage.

  4. 4

    8–10 Weeks

    Available evidence does not describe a distinct sensation at this duration.

  5. 5

    11–15 Weeks

    Continued use is generally evaluated through biomarkers rather than felt sensation.

  6. 6

    16–20 Weeks

    No established human timeline exists to reference at this stage.

  7. 7

    21–24 Weeks

    By this point, any felt-effect assessment would be based on limited available evidence.

⚠️ Research context only. This is not medical advice and results are not guaranteed.